Literature DB >> 31399440

Impact of Depression and Anxiety on Change to Physical Activity Following a Pragmatic Diabetes Prevention Program Within Primary Care: Pooled Analysis From Two Randomized Controlled Trials.

Thomas Yates1,2, Laura J Gray3, Joseph Henson4,2, Charlotte L Edwardson4,2, Kamlesh Khunti4,5, Melanie J Davies4,2.   

Abstract

OBJECTIVE: The impact of major affective disorders on the effectiveness of diabetes prevention programs at promoting health behaviors has not been established. We investigated whether depression modifies the effectiveness of two pragmatic diabetes prevention programs at promoting increased physical activity. RESEARCH DESIGN AND METHODS: This study pooled data from two cluster randomized controlled trials (Walking Away from Type 2 Diabetes and Let's Prevent Type 2 Diabetes) that included individuals at high risk of type 2 diabetes who were recruited from primary care. The trials used very similar intervention methods to promote physical activity and had annual follow-up over a 36-month period. Depressive symptoms were measured by the Hospital Anxiety and Depression Scale, and physical activity was measured by a piezoelectric pedometer (Let's Prevent Type 2 Diabetes) or an accelerometer (Walking Away from Type 2 Diabetes) and expressed as steps per day.
RESULTS: This analysis included 1,163 individuals (571 control, 592 intervention) who had concurrent baseline and follow-up data for ambulatory activity, depression, and anxiety. The median depression score was 3 at baseline; 11% of individuals were classified as having mild to severe depression. Those with no depressive symptoms at baseline or during follow-up increased their ambulatory activity by 592 steps per day (P < 0.001); this effect decayed by 88 steps per day (95% CI 21, 155) for every additional depressive symptom score at baseline, and each increase in the depressive symptom score between baseline and follow-up further attenuated the intervention effect by 99 steps per day (95% CI 2, 196).
CONCLUSIONS: Both depressive symptom burden at baseline and change in this burden are associated with a graded reduction in the effectiveness of diabetes prevention programs at increasing physical activity in primary care.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2019        PMID: 31399440     DOI: 10.2337/dc19-0400

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

1.  Validation of accelerometry as a digital phenotyping measure of negative symptoms in schizophrenia.

Authors:  Gregory P Strauss; Ian M Raugh; Luyu Zhang; Lauren Luther; Hannah C Chapman; Daniel N Allen; Brian Kirkpatrick; Alex S Cohen
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-15

2.  Barriers to participation and lifestyle change among lower versus higher income participants in the National Diabetes Prevention Program: lifestyle coach perspectives.

Authors:  Katherine J W Baucom; Tali Bauman; Manuel Gutierrez Chavez; Yanina Nemirovsky; Monique C Aguirre; Carmen Ramos; Anu Asnaani; Cassidy A Gutner; Natalie D Ritchie; Megha Shah
Journal:  Transl Behav Med       Date:  2022-08-17       Impact factor: 3.626

3.  Depression Status, Lifestyle, and Metabolic Factors With Subsequent Risk for Major Cardiovascular Events: The China Cardiometabolic Disease and Cancer Cohort (4C) Study.

Authors:  Xi Chen; Zhelong Liu; Yan Yang; Gang Chen; Qin Wan; Guijun Qin; Li Yan; Guixia Wang; Yingfen Qin; Zuojie Luo; Xulei Tang; Yanan Huo; Ruying Hu; Zhen Ye; Lixin Shi; Zhengnan Gao; Qing Su; Yiming Mu; Jiajun Zhao; Lulu Chen; Tianshu Zeng; Qiang Li; Feixia Shen; Li Chen; Yinfei Zhang; Youmin Wang; Huacong Deng; Chao Liu; Shengli Wu; Tao Yang; Mian Li; Yu Xu; Min Xu; Tiange Wang; Zhiyun Zhao; Jieli Lu; Yufang Bi; Xuefeng Yu; Weiqing Wang; Guang Ning
Journal:  Front Cardiovasc Med       Date:  2022-05-26

4.  Causal Effects of Positive Affect, Life Satisfaction, Depressive Symptoms, and Neuroticism on Kidney Function: A Mendelian Randomization Study.

Authors:  Sehoon Park; Soojin Lee; Yaerim Kim; Yeonhee Lee; Min Woo Kang; Kwangsoo Kim; Yong Chul Kim; Seung Seok Han; Hajeong Lee; Jung Pyo Lee; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Dong Ki Kim
Journal:  J Am Soc Nephrol       Date:  2021-03-30       Impact factor: 14.978

5.  Exercise as a Moderator of Persistent Neuroendocrine Symptoms of COVID-19.

Authors:  Candida J Rebello; Christopher L Axelrod; Charles F Reynolds; Frank L Greenway; John P Kirwan
Journal:  Exerc Sport Sci Rev       Date:  2022-04-01       Impact factor: 6.642

6.  Psychosocial conditions and the progression of diabetic nephropathy in Japanese with type 2 diabetes mellitus.

Authors:  Hiroyo Ninomiya; Naoto Katakami; Mitsuyoshi Takahara; Taka-Aki Matsuoka; Iichiro Shimomura
Journal:  Diabetol Int       Date:  2021-01-02

7.  Exercise for people living with frailty and receiving haemodialysis: a mixed-methods randomised controlled feasibility study.

Authors:  Hannah M L Young; Daniel S March; Patrick J Highton; Matthew P M Graham-Brown; Darren C Churchward; Charlotte Grantham; Samantha Goodliffe; William Jones; Mei-Mei Cheung; Sharlene A Greenwood; Helen C Eborall; Simon Conroy; Sally J Singh; Alice C Smith; James O Burton
Journal:  BMJ Open       Date:  2020-11-03       Impact factor: 2.692

8.  Promoting physical activity in a multi-ethnic population at high risk of diabetes: the 48-month PROPELS randomised controlled trial.

Authors:  Kamlesh Khunti; Tom Yates; Simon Griffin; Alan Brennan; Helen Dallosso; Melanie J Davies; Helen C Eborall; Charlotte L Edwardson; Laura J Gray; Wendy Hardeman; Laura Heathcote; Joe Henson; Daniel Pollard; Stephen J Sharp; Stephen Sutton; Jacqui Troughton
Journal:  BMC Med       Date:  2021-06-03       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.